These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 34407648)

  • 1. Activation of the trigeminal system as a likely target of SARS-CoV-2 may contribute to anosmia in COVID-19.
    Messlinger K; Neuhuber W; May A
    Cephalalgia; 2022 Feb; 42(2):176-180. PubMed ID: 34407648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Headache as a Symptom of COVID-19: Narrative Review of 1-Year Research.
    Caronna E; Pozo-Rosich P
    Curr Pain Headache Rep; 2021 Nov; 25(11):73. PubMed ID: 34766205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrum of Neurological Manifestations in Covid-19: A Review.
    Garg RK
    Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anosmia: a missing link in the neuroimmunology of coronavirus disease 2019 (COVID-19).
    Yazdanpanah N; Saghazadeh A; Rezaei N
    Rev Neurosci; 2020 Oct; 31(7):691-701. PubMed ID: 32776905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Loss of smell, a preliminary indicator of COVID-19].
    Waizel-Haiat S; Waizel-Bucay J
    Rev Med Inst Mex Seguro Soc; 2021 Feb; 59(1):4-6. PubMed ID: 33666408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study.
    Sampaio Rocha-Filho PA; Albuquerque PM; Carvalho LCLS; Dandara Pereira Gama M; Magalhães JE
    J Headache Pain; 2022 Jan; 23(1):2. PubMed ID: 34979899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Features of olfactory impairment connected with trigeminal nerve system].
    Kryukov AI; Kunelskaya NL; Zaoeva ZO; Baybakova EV; Chugunova MA; Tovmasyan AS; Panasov SA; Yanyushkina ES; Manaenkova EA; Nikitkina YY; Panova TN; Kishinevskii AE
    Vestn Otorinolaringol; 2024; 89(2):33-39. PubMed ID: 38805461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiological mechanisms and management of patients with long-time anosmia related to COVID-19.
    Lechien JR; Chiesa-Estomba CM; Hans S; Saussez S
    J Intern Med; 2021 Aug; 290(2):464-465. PubMed ID: 33527593
    [No Abstract]   [Full Text] [Related]  

  • 9. Olfactory disorder in patients infected with SARS-CoV-2.
    Yen YF; Lai HH; Chan SY; Su VY; Chiu TF; Huang CY; Hung CC; Kuo TL; Lee YL; Chu D
    J Microbiol Immunol Infect; 2021 Oct; 54(5):992-996. PubMed ID: 32859529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Olfactory dysfunction and COVID-19 - current state of the problem].
    Karapetyan LS; Svistushkin VM
    Vestn Otorinolaringol; 2020; 85(6):100-104. PubMed ID: 33474926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does serotonin deficiency lead to anosmia, ageusia, dysfunctional chemesthesis and increased severity of illness in COVID-19?
    Sen A
    Med Hypotheses; 2021 Aug; 153():110627. PubMed ID: 34139598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case Series of Headache Characteristics in COVID-19: Headache Can Be an Isolated Symptom.
    Toptan T; Aktan Ç; Başarı A; Bolay H
    Headache; 2020 Sep; 60(8):1788-1792. PubMed ID: 32790216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anosmia Is a Key Symptom of COVID-19 Infection and Should Be Used as a Diagnostic Tool.
    Lechien JR; Barillari MR; Jouffe L; Saussez S
    Ear Nose Throat J; 2020 Nov; 99(9):577-578. PubMed ID: 32436441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Headache characteristics in COVID-19 pandemic-a survey study.
    Uygun Ö; Ertaş M; Ekizoğlu E; Bolay H; Özge A; Kocasoy Orhan E; Çağatay AA; Baykan B
    J Headache Pain; 2020 Oct; 21(1):121. PubMed ID: 33050880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the olfactory bulb volume and morphology in patients with coronavirus disease 2019: can differences create predisposition to anosmia?
    Akkaya H; Kizilog Lu A; Dilek O; Belibag Li C; Kaya Ö; Yılmaz C; Gülek B
    Rev Assoc Med Bras (1992); 2021 Oct; 67(10):1491-1497. PubMed ID: 35018981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anosmia and Ageusia: Common Findings in COVID-19 Patients.
    Vaira LA; Salzano G; Deiana G; De Riu G
    Laryngoscope; 2020 Jul; 130(7):1787. PubMed ID: 32237238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could COVID-19 anosmia and olfactory dysfunction trigger an increased risk of future dementia in patients with ApoE4?
    Manzo C; Serra-Mestres J; Isetta M; Castagna A
    Med Hypotheses; 2021 Feb; 147():110479. PubMed ID: 33422806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-COVID-19 neuropsychiatric manifestations among COVID-19 survivors suffering from migraine: a case-control study.
    Magdy R; Elmazny A; Soliman SH; Elsebaie EH; Ali SH; Abdel Fattah AM; Hassan M; Yassien A; Mahfouz NA; Elsayed RM; Fathy W; Abdel-Hamid HM; Mohamed J; Hussein M
    J Headache Pain; 2022 Aug; 23(1):101. PubMed ID: 35962348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Headache as a Cardinal Symptom of Coronavirus Disease 2019: A Cross-Sectional Study.
    Membrilla JA; de Lorenzo Í; Sastre M; Díaz de Terán J
    Headache; 2020 Nov; 60(10):2176-2191. PubMed ID: 32989732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paranasal sinuses computed tomography findings in anosmia of COVID-19.
    Naeini AS; Karimi-Galougahi M; Raad N; Ghorbani J; Taraghi A; Haseli S; Mehrparvar G; Bakhshayeshkaram M
    Am J Otolaryngol; 2020; 41(6):102636. PubMed ID: 32652405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.